Author/Authors :
Mohammadzadeh Mehdi نويسنده Tabriz Health Center, Tabriz, Iran. Mohammadzadeh Mehdi , Fattahi Behnaz نويسنده School of Pharmacy, Islamic Azad University, Tehran,
Iran , Ghari Tayebeh نويسنده Department of Pharmaceutics, School of pharmacy, Alborz
University of Medical Sciences, Karaj, Iran
Abstract :
One of the most important public health concerns in both
developing and developed countries is viral hepatitis B. It is an
autoimmune liver disease, which imposes a high economic burden on
individuals and the society. The aim of our study was to determine
economic burden of hepatitis B virus (HBV) infection in Iran. To this
end, 300 patients with HBV infection, who referred to hospitals in three
cities of Iran during the year 2015, were randomly selected. To estimate
the total burden of hepatitis, direct and indirect costs, costs of DALYs
and social welfare were calculated which gave the costs of 7500.93 PPP$
and 96782 PPP$, respectively. Finally, our results showed that the total
economic burden of HBV in Iran is dramatic which can lead to decreased
quality of life of household members and damage the economy of the
society. Therefore, the benefit of prevention and control measures will
justify the costs from social perspective.
